Ophthalmic Viscoelastic devices Market Size

Market Size Snapshot

Note – Market size depicts the revenue generated over the financial year

The market for ophthalmic viscoelastics is growing at a steady rate, from an expected value of $2,135,903,767 in 2024 to $3,527,511,673 in 2035. This growth is reflected in a CAGR of 4.6% from 2025 to 2035. The growing prevalence of eye diseases, the rising number of cataract operations, and the development of surgical techniques are all important factors driving the growth of the market. In addition, the increasing use of minimally invasive surgical methods is increasing the demand for ophthalmic viscoelastics, which play a crucial role in preventing the loss of pressure in the eye during surgery and protecting the ocular tissues. Alcon, Bausch & Lomb, and Johnson & Johnson are the leading manufacturers of ophthalmic viscoelastics. These companies are also involved in strategic alliances to increase their market share and develop their product portfolios. Recently launched viscoelastics with improved properties and improved patient outcomes are also expected to drive market growth. Moreover, the market is expected to continue to grow at a steady rate, mainly driven by technological advancements and an increasing focus on eye health.

Regional Market Size

Regional Deep Dive

The Ophthalmic Viscoelastics Devices Market is characterized by significant growth potential across different regions, driven by the rising prevalence of eye disorders, advancements in surgical techniques, and an increasing geriatric population. Each region is characterized by its own market dynamics, influenced by the existing healthcare structure, regulatory environment, and technological advancements. Minimally invasive procedures are driving the adoption of ophthalmic viscoelastic devices, making them a critical component of cataract and other eye surgeries across the world.

Europe

• In Europe the market is strongly influenced by the high standards of regulation and the emphasis on clinical proof, which has resulted in the development of high quality ophthalmic viscoelastics. The big players like Johnson & Johnson and Carl Zeiss Meditec are working on solutions that meet the special requirements of the European health care systems.
• Under the heading of ophthalmic viscoelastics, the market is expected to grow at a CAGR of 4.6% between 2017 and 2023. This investment in innovation will increase competition and promote collaboration between key players.

Asia Pacific

• In the Asia-Pacific region, the market for ophthalmic viscoelastics is growing rapidly, due to increasing expenditure on health and the rising prevalence of eye diseases. In countries like India and China, the number of cataract operations is rising sharply, and this has pushed up the demand for viscoelastics.
• There are now some local manufacturers of eye-glasses, such as Oculentis and Hoya Optical, which are expanding their product lines to meet the demand. This is expected to make eye-surgery more accessible and affordable.

Latin America

• Latin America is characterized by a heterogeneous health care system, with varying access to ophthalmic technology. Brazil and Mexico are witnessing a rise in cataract surgery, which in turn is driving demand for viscoelastic devices.
• Regulatory authorities are increasingly recognizing the importance of innovations in ophthalmology, resulting in faster approval of new products. This is expected to spur the growth of both domestic and foreign companies.

North America

• The American market is undergoing a boom in the use of viscoelastics, with the introduction of new formulations that have been shown to improve surgical results. Alcon and Bausch & Lomb are leading the way with their newer products, which are aimed at improving patient safety and surgical efficiency.
• In the United States, regulatory changes have made the process of obtaining approval for new ophthalmic devices much more straightforward, which has encouraged more companies to invest in research and development. These developments have resulted in a faster introduction of new products, such as biodegradable viscoelastics, which are expected to change surgical practices.

Middle East And Africa

• Among the ophthalmic viscoelastics market in the Middle East and Africa, the most important factors are the growing awareness of eye health and the increasing investment in health care. Governments are launching projects to improve access to eye care, which is driving the demand for surgical devices.
• The World Health Organization has been encouraging international cooperation in the fight against blindness. This is expected to lead to a greater use of advanced surgical methods and equipment.

Did You Know?

“Did you know that the first use of viscoelastic substances in ophthalmic surgery dates back to the 1970s, and since then, these devices have evolved significantly to improve surgical outcomes and patient safety?” — Ophthalmic Surgery, Lasers & Imaging Retina Journal

Segmental Market Size

Ophthalmic viscoelastics play a crucial role in the ophthalmic surgery market, especially in the fields of cataract and glaucoma surgery, and currently are experiencing stable growth. The key growth drivers are the increasing prevalence of eye disorders that necessitate surgical intervention, and the development of surgical techniques that improve patient outcomes. The increasing demand for medical devices also is a significant contributor to the growth of this market. The ophthalmic viscoelastics market has reached a mature stage. The major players, such as Alcon and Bausch & Lomb, lead the market with their advanced products. These viscoelastics are primarily used to maintain the stability of the anterior chamber during surgery and to facilitate the insertion of the intraocular lens. The increasing prevalence of eye disorders, the increasing aging of the population, and the increasing trend toward minimally invasive surgery all are expected to accelerate the growth of the market. These viscoelastics are expected to continue to play an important role in ophthalmic surgery in the future, owing to technological developments such as the development of smart viscoelastics that respond to physiological changes.

Future Outlook

Ophthalmic viscoelastics are set to show significant growth from 2024 to 2035. Their market value is forecast to increase from $ 2.13 billion to $ 3.50 billion, with a CAGR of 4.3 percent. The growth is primarily driven by the increasing prevalence of ocular diseases, an aging population, and advances in surgical techniques that necessitate the use of viscoelastics in cataract and glaucoma surgery. These trends will result in an increasing demand for viscoelastics that improve the outcome of surgical procedures, which will lead to an increase in market penetration and usage rates. Technological advancements such as the development of new formulations that improve the performance and safety profiles of viscoelastics will also support growth. In addition, the development of viscoelastics with cohesive and dispersive properties for specific surgical applications is expected to enhance the effectiveness of these products. Moreover, supportive government policies and increasing government spending on ophthalmic research will foster a favorable environment for growth. Artificial intelligence in surgical procedures and the increasing use of minimally invasive techniques will also shape the future of the viscoelastics market.